Tuberous Sclerosis
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
280
|
35
|
0.100 |
None |
0.993 |
137 |
|
2002 |
2020 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6241
|
355
|
0.100 |
None |
1.000 |
71 |
|
2001 |
2020 |
Conventional (Clear Cell) Renal Cell Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2274
|
203
|
0.600 |
None |
0.984 |
63 |
|
2005 |
2020 |
Liver carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
5541
|
769
|
0.400 |
None |
0.983 |
55 |
|
2007 |
2020 |
Epilepsy
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
1124
|
250
|
0.100 |
None |
1.000 |
38 |
|
2010 |
2020 |
Alzheimer's Disease
|
disease |
Nervous System Diseases; Mental Disorders
|
Disease or Syndrome
|
3131
|
968
|
0.100 |
None |
1.000 |
38 |
|
2005 |
2019 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.100 |
None |
1.000 |
31 |
|
2008 |
2020 |
Glioblastoma Multiforme
|
disease |
Neoplasms
|
Neoplastic Process
|
3155
|
160
|
0.600 |
None |
0.967 |
29 |
|
2005 |
2019 |
Neuroendocrine Tumors
|
group |
Neoplasms
|
Neoplastic Process
|
481
|
16
|
0.100 |
None |
0.964 |
28 |
|
2012 |
2019 |
Non-Small Cell Lung Carcinoma
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
3882
|
601
|
0.400 |
None |
1.000 |
28 |
|
2006 |
2019 |
Metastatic Renal Cell Cancer
|
disease |
|
Neoplastic Process
|
145
|
9
|
0.100 |
None |
1.000 |
27 |
|
2009 |
2020 |
Metastatic Renal Cell Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
144
|
9
|
0.100 |
None |
1.000 |
27 |
|
2009 |
2020 |
Hyperactive behavior
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Mental or Behavioral Dysfunction
|
1121
|
100
|
0.200 |
None |
1.000 |
26 |
|
2013 |
2020 |
Glioblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
3131
|
157
|
0.500 |
None |
0.967 |
26 |
|
2005 |
2019 |
Diabetes Mellitus
|
group |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
2650
|
714
|
0.100 |
None |
1.000 |
26 |
|
2011 |
2020 |
Leukemia, Myelocytic, Acute
|
disease |
Neoplasms
|
Neoplastic Process
|
2428
|
247
|
0.100 |
None |
1.000 |
23 |
|
2009 |
2019 |
Seizures
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
1052
|
139
|
0.200 |
None |
0.957 |
23 |
|
2012 |
2020 |
Parkinson Disease
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
1952
|
751
|
0.100 |
None |
1.000 |
21 |
|
2008 |
2020 |
Diabetes
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
2314
|
611
|
0.100 |
None |
1.000 |
20 |
|
2011 |
2020 |
Lupus Erythematosus, Systemic
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases
|
Disease or Syndrome
|
1686
|
635
|
0.100 |
None |
1.000 |
19 |
|
2008 |
2020 |
Multiple Myeloma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases; Cardiovascular Diseases
|
Neoplastic Process
|
1674
|
118
|
0.100 |
None |
0.947 |
19 |
|
2002 |
2019 |
Lymphangioleiomyomatosis
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
92
|
2
|
0.100 |
None |
0.944 |
18 |
|
2008 |
2019 |
Immunosuppression
|
disease |
|
Disease or Syndrome
|
632
|
9
|
0.100 |
None |
0.944 |
18 |
|
2017 |
2020 |
Diabetes Mellitus, Non-Insulin-Dependent
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
2694
|
1598
|
0.300 |
None |
1.000 |
18 |
|
2005 |
2019 |
Neurodegenerative Disorders
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
1480
|
85
|
0.100 |
None |
1.000 |
17 |
|
2011 |
2020 |